Drug Shortage Report for SURVANTA

Last updated on 2018-08-30 History
Report ID 56829
Drug Identification Number 02016109
Brand name SURVANTA
Common or Proper name SURVANTA VIAL, 4mL
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) BERACTANT
Strength(s) 25MG
Dosage form(s) SUSPENSION
Route of administration INTRATRACHEAL
Packaging size 4mL vial
ATC code R07AA
ATC description OTHER RESPIRATORY SYSTEM PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-07-24
Estimated end date 2018-09-04
Actual end date 2018-08-29
Shortage status Resolved
Updated date 2018-08-30
Company comments We are currently monitoring our inventory of Survanta 4mL due to an unexpected increase in market demand. We have normal inventory levels of Survanta 8mL. During that period, orders will be processed to prioritize patient needs.
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-27 English Compare
v2 2018-07-27 English Compare
v3 2018-07-27 English Compare
v4 2018-07-27 French Compare
v5 2018-07-27 English Compare
v6 2018-07-27 French Compare
v7 2018-08-30 English Compare
v8 2018-08-30 French Compare

Showing 1 to 8 of 8